Value Sense
CVS
CVS Health Corporation (CVS)
Last Price$64.9(1.2%)
Market Cap$82.3B
EV/OCF LTM
27.8x
5Y avg
12.0x
Medical - Healthcare Plans industry median
14.5x
Stock quality & Intrinsic value
5/10
2.2% undervalued
CVS
is 220.8% undervalued
learn more -->
50+
undervalued stocks
Start beating the S&P 500

CVS Health Corporation EV/OCF LTM

Annual
Quarterly
Daily
Crunching data... Almost there!
Dec'05Dec'06Dec'07Dec'08Dec'09Dec'10Dec'11Dec'12Dec'13Dec'14Dec'15Dec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24
EV/OCF LTM
22.9x
18.0x
25.2x
13.9x
14.0x
12.0x
9.1x
11.9x
15.7x
19.5x
16.2x
9.4x
9.4x
15.0x
14.0x
11.0x
11.4x
7.8x
11.7x
27.8x
CVS
Key metrics and insights to make informed decisions.
View full analysis
Overvalued or undervalued?
Check the intrinsic value for CVS and see if it's the right time to invest.
Dive in

CVS Health Corporation (CVS) EV/OCF LTM comparison analysis

General

LTM EV/OCF LTM

OTHER METRICS

Company name

Revenue growth

EPS growth

Net Income margin

CVS Health Corporation logo
CVS Health CorporationCVS
16.9x
4.2%
(43.6%)
1.2%
Median Peer Set
14.5x
8.9%
(4.8%)
2.0%
Centene Corporation logo
Centene CorporationCNC
201.0x
5.9%
27.4%
2.0%
Alignment Healthcare, Inc. logo
Alignment Healthcare, Inc.ALHC
77.1x
27.2%
(4.8%)
(8.1%)
Molina Healthcare, Inc. logo
Molina Healthcare, Inc.MOH
24.5x
19.3%
9.2%
2.9%
UnitedHealth Group Incorporated logo
UnitedHealth Group IncorporatedUNH
17.0x
8.9%
(35.7%)
3.6%
Elevance Health Inc. logo
Elevance Health Inc.ELV
14.5x
3.2%
(0.0%)
3.4%
Clover Health Investments, Corp. logo
Clover Health Investments, Corp.CLOV
12.7x
(41.5%)
(31.3%)
(10.5%)
Cigna Corporation logo
Cigna CorporationCI
10.7x
8.4%
(18.9%)
2.6%
Humana Inc. logo
Humana Inc.HUM
7.7x
10.7%
(50.1%)
1.0%
Oscar Health, Inc. logo
Oscar Health, Inc.OSCR
1.9x
56.5%
N/A
0.3%

CVS key stats

USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Dec'05Dec'06Dec'07Dec'08Dec'09Dec'10Dec'11Dec'12Dec'13Dec'14Dec'15Dec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24
Revenue
% growth
37,006.7
21.0%
43,821.4
18.4%
76,329.5
74.2%
87,472.0
14.6%
98,215.0
12.3%
95,778.0
(2.5%)
107,080.0
11.8%
123,120.0
15.0%
126,761.0
3.0%
139,367.0
9.9%
153,290.0
10.0%
177,546.0
15.8%
184,786.0
4.1%
194,579.0
5.3%
256,776.0
32.0%
268,706.0
4.6%
292,111.0
8.7%
322,467.0
10.4%
357,776.0
10.9%
372,809.0
4.2%
Cost of Goods Sold (COGS)27,312.132,079.260,221.869,182.077,857.075,559.086,518.0100,632.0102,978.0114,000.0126,762.0148,712.0156,258.0163,041.0211,248.0219,660.0239,991.0267,965.0303,345.0321,408.0
Gross Profit
% margin
9,694.6
26.2%
11,742.2
26.8%
16,107.7
21.1%
18,290.0
20.9%
20,358.0
20.7%
20,219.0
21.1%
20,562.0
19.2%
22,488.0
18.3%
23,783.0
18.8%
25,367.0
18.2%
26,528.0
17.3%
28,834.0
16.2%
28,528.0
15.4%
31,538.0
16.2%
45,528.0
17.7%
49,046.0
18.3%
52,120.0
17.8%
54,502.0
16.9%
54,431.0
15.2%
51,401.0
13.8%
Operating Expenses7,675.19,300.611,314.412,244.013,933.014,082.014,231.015,278.015,746.016,568.017,053.018,448.018,990.027,517.033,541.035,135.038,810.046,548.040,688.041,606.0
Research & Development Expenses (R&D)0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Selling, General & Administrative Expenses (SG&A)7,675.19,300.611,314.412,244.213,933.014,092.014,231.00.00.00.00.00.00.00.00.00.00.00.00.0(1,279.0)
Operating Income
% margin
2,019.5
5.5%
2,441.6
5.6%
4,793.3
6.3%
6,046.0
6.9%
6,425.0
6.5%
6,137.0
6.4%
6,331.0
5.9%
7,210.0
5.9%
8,037.0
6.3%
8,799.0
6.3%
9,475.0
6.2%
10,386.0
5.8%
9,538.0
5.2%
4,021.0
2.1%
11,987.0
4.7%
13,911.0
5.2%
13,310.0
4.6%
7,954.0
2.5%
13,743.0
3.8%
8,516.0
2.3%
Interest Income0.00.00.021.05.03.04.04.08.015.021.020.021.00.00.00.00.00.00.00.0
Interest Expense0.00.00.0530.0530.0539.0588.0561.0517.0615.0859.01,078.01,062.02,619.03,035.02,907.02,503.02,287.02,658.02,958.0
Pre-tax Income1,909.02,225.84,358.75,537.05,900.05,601.05,747.06,305.07,528.07,678.08,616.08,637.08,268.01,406.08,997.09,770.010,537.05,836.011,173.06,148.0
Income Tax
% effective tax rate
684.3
35.8%
856.9
38.5%
1,721.7
39.5%
2,193.0
39.6%
2,200.0
37.3%
2,179.0
38.9%
2,258.0
39.3%
2,436.0
38.6%
2,928.0
38.9%
3,033.0
39.5%
3,386.0
39.3%
3,317.0
38.4%
1,637.0
19.8%
2,002.0
142.4%
2,366.0
26.3%
2,569.0
26.3%
2,548.0
24.2%
1,509.0
25.9%
2,805.0
25.1%
1,562.0
25.4%
Net Income
% margin
1,224.7
3.3%
1,368.9
3.1%
2,637.0
3.5%
3,212.0
3.7%
3,696.0
3.8%
3,427.0
3.6%
3,462.0
3.2%
3,864.0
3.1%
4,592.0
3.6%
4,644.0
3.3%
5,237.0
3.4%
5,317.0
3.0%
6,622.0
3.6%
(594.0)
(0.3%)
6,634.0
2.6%
7,179.0
2.7%
8,001.0
2.7%
4,311.0
1.3%
8,344.0
2.3%
4,614.0
1.2%
EPS1.491.651.972.232.582.512.593.053.773.984.664.936.47(0.57)5.105.486.003.296.493.66
Diluted EPS1.451.601.922.182.552.492.573.033.743.964.634.906.44(0.57)5.085.465.953.266.473.66
EBITDA
% margin
2,608.6
7.0%
3,174.9
7.2%
5,887.9
7.7%
7,341.0
8.4%
7,819.0
8.0%
7,609.0
7.9%
7,903.0
7.4%
8,619.0
7.0%
9,915.0
7.8%
10,224.0
7.3%
11,567.0
7.5%
12,190.0
6.9%
11,809.0
6.4%
6,743.0
3.5%
16,403.0
6.4%
17,118.0
6.4%
17,526.0
6.0%
12,347.0
3.8%
18,197.0
5.1%
13,703.0
3.7%

Discover more Stock Ideas

Undervalued stocks right now

Undervalued stocks right now

Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.

3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%
Undervalued growth stocks

Undervalued growth stocks

Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.

3M Return 35.3%
S&P Outperformance 22.3%
Next 3M Predicted Return 26.8%
Undervalued dividend stocks

Undervalued dividend stocks

Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.

3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%
More ideas -->

FAQ

1) What is CVS Health Corporation's EV/OCF LTM?

As of today, Microsoft Corp's last 12-month EV/OCF LTM is 27.8x, based on the financial report for Dec 30, 2024 (Q4’2024). The average annual EV/OCF LTM for CVS Health Corporation have been 12.2x over the past three years, and 12.6x over the past five years.

2) Is CVS Health Corporation's EV/OCF LTM Good?

As of today, CVS Health Corporation's EV/OCF LTM is 27.8x, which is higher than industry median of 14.5x. It indicates that CVS Health Corporation's EV/OCF LTM is Bad.

3) How does CVS Health Corporation's EV/OCF LTM compare to its peers?

As of today, CVS Health Corporation's EV/OCF LTM is 27.8x, which is higher than peer median of 14.5x. The list of peers includes CNC, ALHC, MOH, UNH, ELV, CLOV, CI, HUM, OSCR.